• |
  • |
  • |
  • |
Donate

Product

Journal: State-of-the-art therapies for fragile X syndrome

Center:
Fiscal Year:
2024
Contact Information:
Product Description:
There are no approved medications for FXS; however, there are several interventions and treatments aimed at managing the symptoms and improving the quality of life of individuals with FXS. A combination of non-pharmacological therapies and pharmacotherapy is currently the most effective treatment for FXS.
Keyword(s):
fragile x syndrome, medications, quality of life
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A